Pilot Study Testing an Online-delivered Psychological Intervention for Indian Expatriates in Sweden Who Experience Dysfunctional Worry
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- Generalized Anxiety Disorder Scale-7 (GAD-7)
研究概览
简要总结
Background: Expatriates may face challenges through distance from support systems, cultural adjustments, and language barriers, which may be associated with anxiety and elevated worry, particularly in times of ongoing global crises. Brief online cognitive-behavioral therapy (ICBT) is effective for treating excessive worry but has not been adapted for expatriate communities in Sweden.
详细描述
This pilot study aimed to investigate the feasibility, acceptability, and preliminary treatment effects of a five-week, therapist-guided, culturally adapted ICBT program. The program targeted excessive worry related to ongoing global crises among Indian expatriates.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •identifying as Indian expatriate currently living in Sweden
- •self-reported dysfunctional worry, defined as worrying several times a day and the worry being experienced as difficult to control
- •age ≥ 18 years;
- •able to provide digital informed consent
- •having daily access to a device with internet connection.
排除标准
- •non-English speaking
- •self-reported severe depression (>28 points on the Montgomery Åsberg Depression Rating Scale (MADRS-S; (Svanborg & Åsberg, 1994)
- •suicidal risk (5 points on item 9 on the MADRS-S).
结局指标
主要结局
Generalized Anxiety Disorder Scale-7 (GAD-7)
时间窗: Baseline to 1-month follow-up ( 9 weeks)
The GAD-7 is a 7-item self-report tool used to assess generalized anxiety disorder severity. It scores symptoms like worry and restlessness over the past two weeks on a scale of 0 to 3, with a total score of 0-21. Scores categorize anxiety as mild, moderate, or severe.
次要结局
- Montgomery Åsberg Depression Rating Scale - Self report (MADRS-S)(Baseline to 1-month follow-up ( 9 weeks))
- Work and Social Adjustment Scale (WSAS)(Baseline to 1-month follow-up ( 9 weeks))
- Insomnia Severity Index(Baseline to 1-month follow-up ( 9 weeks))
- Client Satisfaction Questionnaire CSQ(Baseline to post-treatment (5 weeks))
- Adverse events(Baseline to 1-month follow-up ( 9 weeks))
- Adherence to treatment(From baseline to treatment (5 weeks))
研究者
Nitya Jayaram-Lindstrom
PhD, Director of Centre for Psychiatry Research
Karolinska Institutet